Patents by Inventor Liangwei QIAN

Liangwei QIAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092729
    Abstract: The present invention relates to a method for purifying key intermediates of Citalopram, i.e. 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-hydroxymethylbenzonitrile and a salt thereof. The method comprises dissolving crude 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-hydroxymethylbenzonitrile (compound of formula I containing formaldehyde impurity) with an organic solvent, adding a washing solution, controlling the temperature, stirring, leaving to stand for layering, and removing the aqueous layer, so as to obtain a purified organic solution of 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-hydroxymethylbenzonitrile. The method provided by the present invention can effectively remove aldehyde group-containing impurities in the intermediate. The method of the present invention has the advantages of simple operation, cheap raw materials and mild conditions, and is suitable for large-scale industrial production.
    Type: Application
    Filed: December 28, 2021
    Publication date: March 21, 2024
    Applicants: ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., Zhejiang Huahai LiCheng Pharmaceutical Co., Ltd.
    Inventors: Jian ZHANG, Jichao WANG, Xiangqian YOU, Liangwei QIAN, Tao ZHOU, Jiaxing HU, Wenfeng HUANG